Healthcare Services

Primary Care POC Diagnostics Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

April 6, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Primary Care POC Diagnostics Market In 2026 And What Value Is Projected For 2030?

The primary care poc diagnostics market size has shown substantial growth recently. It is forecast to grow from $17.38 billion in 2025 to $18.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.0%. The expansion observed historically is attributable to factors including the increasing prevalence of infectious and chronic diseases, wider adoption of glucose and cardiometabolic testing, expansion of primary care diagnostic capabilities, increased use of otc diagnostic products, and improved accessibility of rapid tests.

The primary care poc diagnostics market size is projected to experience robust expansion in the coming years. It is anticipated to reach $24.6 billion by 2030, advancing at a compound annual growth rate (CAGR) of 7.3%. This projected growth can be ascribed to several factors, including the increasing demand for decentralized diagnostics, the rising integration of AI-enabled diagnostics, the expansion of telehealth-supported testing, a growing focus on preventive screening, and increasing investments in personalized diagnostics. Throughout the forecast period, significant trends are expected to involve the increasing adoption of rapid diagnostic testing, the growing integration of digital PoC devices, a rising demand for home-use diagnostic kits, the expansion of multiplex testing platforms, and an enhanced focus on early disease detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Primary Care POC Diagnostics Market?

The increasing occurrence of infectious diseases is anticipated to boost the expansion of the primary care POC diagnostics market in the future. These ailments are caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, and they can transmit between individuals either directly or indirectly through contact with contaminated surfaces, air, water, or vectors like insects. The widespread nature of infectious diseases stems from factors such as substandard environmental conditions, increasing urbanization, antimicrobial resistance, and insufficient vaccination rates. Primary care POC diagnostics serve as crucial instruments in combating infectious disease prevalence, enabling prompt detection, timely interventions, and efficient disease management across various healthcare environments. For example, data from March 2025 by the US federal agency, the Centers for Disease Control and Prevention (CDC), showed an increase in tuberculosis cases from 9,622 in 2023 to 10,347 in 2024 (an 8% increase). Concurrently, the incidence rate climbed from 2.9 to 3.0 per 100,000 population (a 6% rise). Consequently, the growing prevalence of infectious diseases is a key driver for the primary care POC diagnostics market.

What Are The Key Segments Of The Primary Care POC Diagnostics Market?

The primary care poc diagnostics market covered in this report is segmented –

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products

2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses

Subsegments:

1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices

What Industry Trends Are Redefining The Primary Care POC Diagnostics Market?

Leading companies in the primary care POC diagnostics market are focusing on the development of advanced microfluidic-based rapid susceptibility testing to improve timely antibiotic decision-making. This microfluidic rapid susceptibility testing employs minuscule fluid channels to swiftly isolate and cultivate bacteria, enabling an early determination of their response to various antimicrobials and reducing the waiting period for results. For example, in June 2023, Sysmex Corporation, a Japan-based diagnostic solutions firm, launched its PA-100 AST System, which features proprietary microfluidic technology. This system can identify bacteria from urine samples in about 15 minutes and deliver antimicrobial susceptibility test (AST) results in as little as 30 minutes during the initial clinic visit. The analyzer is compact, designed to fit on a desktop, and operates with reagent cartridges where samples are directly placed for automatic measurement. Healthcare professionals without specialized lab training can operate it easily. By accelerating diagnostics, the device supports appropriate antimicrobial use during initial patient visits and aids in the global battle against antimicrobial resistance.

Who Are The Leading Companies Operating In The Primary Care POC Diagnostics Market?

Major companies operating in the primary care poc diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Read the full primary care poc diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

What Are The Leading Geographic Regions In The Primary Care POC Diagnostics Market?

North America was the largest region in the primary care POC diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care poc diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Primary Care POC Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2026, By The Business Research Company

Direct Primary Care Global Market Report

https://www.thebusinessresearchcompany.com/report/direct-primary-care-global-market-report

Direct Primary Care Global Market Report

https://www.thebusinessresearchcompany.com/report/direct-primary-care-global-market-report

Physician And Other Health Practitioner Global Market Report

https://www.thebusinessresearchcompany.com/report/physician-and-other-health-practitioner-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795